Profusa Announces Listing Transfer to The Nasdaq Capital Market

BERKELEY, CA, May 15, 2026 (GLOBE NEWSWIRE) --  Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a  digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry, announces  that, effective May 15, 2026, the Company will now be listed on The Nasdaq Capital Market.  The move is the first of a previously announced series of interim milestones as laid out by the Nasdaq Hearings Panel to ensure continued compliance with the bid price and stockholders' equity requirements for continued listing on the Capital Market tier.